857854-81-0

Basic information

• Product Name: (3R)-3-(4-bromophenoxy)tetrahydrofuran
• Synonyms: (3R)-3-(4-bromophenoxy)tetrahydrofuran
• CAS NO: 857854-81-0
• Molecular Weight: 243.1
• Mol File: 857854-81-0.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (3R)-3-(4-bromophenoxy)tetrahydrofuran(CAS DataBase Reference)
• NIST Chemistry Reference: (3R)-3-(4-bromophenoxy)tetrahydrofuran(857854-81-0)
• EPA Substance Registry System: (3R)-3-(4-bromophenoxy)tetrahydrofuran(857854-81-0)

Safety Data

• Hazardous Substances Data: 857854-81-0(Hazardous Substances Data)

Usage

General Description

(3R)-3-(4-bromophenoxy)tetrahydrofuran is a chemical compound with the molecular formula C10H11BrO2. It is a tetrahydrofuran derivative with a bromophenoxy group attached to the third carbon atom. (3R)-3-(4-bromophenoxy)tetrahydrofuran is commonly used in organic synthesis and pharmaceutical research due to its unique structure and properties. It is also used as a building block in the synthesis of various compounds and as a starting material for the preparation of biologically active molecules. Additionally, (3R)-3-(4-bromophenoxy)tetrahydrofuran is of interest for its potential pharmaceutical applications, particularly in the development of new drugs for the treatment of various medical conditions.

Upstream product

• 106-41-2 4-bromo-phenol 
• 86087-23-2 (S)-3-hydroxytetyrahydrofurane 
• 918439-76-6 (3S)-3-iodotetrahydrofuran 
• 112052-11-6 toluene-4-sulfonic acid (S)-(tetrahydrofuran-3-yl)ester 

Downstream Products

• 1416157-65-7 2-(4-((R)-tetrahydrofuran-3-yloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 857854-83-2 (2-benzyloxy-phenyl)-[4-((R)-tetrahydrofuran-3-yloxy)phenyl]-methanol 

Relevant articles and documents

Nitrogen-containing fused tricyclic derivative and application thereof

The invention discloses a nitrogen-containing fused tricyclic derivative and application thereof, and particularly relates to a novel nitrogen-containing fused tricyclic derivative and a pharmaceutical composition containing the nitrogen-containing fused tricyclic derivative, and the nitrogen-containing fused tricyclic derivative can be used as a selective adenosine A2A receptor antagonist. The invention also relates to a method for preparing the compound and the pharmaceutical composition and application of the compound and the pharmaceutical composition in preparation of drugs for treating adenosine A2A receptor related diseases, especially Parkinson's disease.

NEW PYRROLIDINE DERIVATIVES AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS

The invention relates to new pyrrolidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

Pyrimidine compounds and methods of making and using same

Disclosed herein are pyrimidinyl compounds that are contemplated to be modulators of cystic fibrosis transmembrane regulators (CFTR), and methods of making and using same. Also provided are pharmaceutical compositions and methods of treating disorders associated with cystic fibrosis transmembrane regulators, such as airway inflammation, cystic fibrosis, and the like.